ESPERION THERAPEUTICS INC (ESPR)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Sheldon L. Koenig President and Chief Executive Officer | 2025 | $770,833 | $0 | $1,260,000 | $847,929 | $639,375 | $17,375 | $3,535,512 |
| 2024 | $745,833 | $0 | $930,700 | $982,162 | $487,500 | $29,045 | $3,175,240 | |
| 2023 | $720,833 | $0 | $422,100 | $1,267,661 | $541,938 | $16,033 | $2,968,565 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| John B. Harlow, Jr. Chief Commercial Officer | 2025 | $66,875 | $35,000 | $1,608,991 | $1,101,468 | $0 | $769 | $2,813,103 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Benjamin Halladay Chief Financial Officer | 2025 | $495,833 | $0 | $357,000 | $239,852 | $247,500 | $11,750 | $1,351,935 |
| 2024 | $467,333 | $0 | $348,500 | $305,969 | $235,125 | $11,500 | $1,368,427 |